Qualified sourcing.
Sourcing is designed around qualified suppliers of EU-GMP pharmaceutical inputs. Altanova’s specifications define the qualification standard suppliers are assessed against, with franchise-specific standards added where the product class requires them.
Supplier enquiries
Predictable capacity.
The manufacturing model is built around licensed contract manufacturers operating under pharmaceutical regulations. Qualification criteria cover EU-GMP status and batch traceability.
Manufacturing enquiries
The medical channel.
Distribution is designed to route through narcotics-licensed Swiss and European pharmacies and authorised pharmaceutical wholesalers operating under EU-GDP and national narcotics authorisations.
Pharmacy enquiries
Clinical collaboration.
Medical engagement is structured around safety data, published clinical evidence and controlled scientific exchange, within the limits that apply to prescription medicines.
Medical enquiries
Expanding the platform.
Altanova evaluates collaborations with complementary healthcare platforms that strengthen the regulated access layer. Each opportunity is assessed for strategic fit and alignment.
Strategic enquiries